Published on
Emergency And Acute Medicine – Hellp Syndrome


Basics And Description
HELLP syndrome is defined by hemolysis, elevated liver enzymes, and low platelet count. It exists on a continuum with severe preeclampsia, as most affected patients are hypertensive, although a subset may have normal blood pressure. Hepatic involvement is the hallmark feature, but other organs such as the brain, kidneys, and lungs may also be affected.
The condition is categorized into three severity classes based on the platelet nadir. Class 1 represents the most severe form with platelet counts below 50,000/μL and accounts for most maternal deaths. Class 2 involves platelet counts between 50,000 and 100,000/μL, while Class 3 is the least severe with platelet counts between 100,000 and 150,000/μL. Increased mortality is associated with hepatic hemorrhage and central nervous system or cardiopulmonary complications. HELLP syndrome occurs in approximately 0.2% of all pregnancies, affects 20% of pregnancies with severe preeclampsia or eclampsia, and may present antepartum, intrapartum, or postpartum.


Risk Factors And Epidemiology
Patients are often white, multiparous, and of older maternal age. Infant mortality is higher in pregnancies complicated by HELLP syndrome.


Etiology And Pathophysiology
The exact cause is unclear, but widespread vasospasm is central to disease development. Fetal–placental debris enters the maternal circulation, triggering a systemic inflammatory response. Vasoconstriction increases vascular resistance and contributes to hypertension. Endothelial injury leads to intercellular leakage, platelet activation, fibrin deposition, and microvascular thrombosis. These processes result in tissue hypoxia, hemorrhage, necrosis, and end-organ damage.


Clinical Presentation And Symptoms
Patients may present with nonspecific flulike symptoms including fatigue and malaise. Common complaints include nausea, vomiting, right upper quadrant or epigastric pain that worsens with disease severity, and headache often accompanied by visual changes.
High-risk symptoms include dyspnea or signs of fluid overload suggesting pulmonary edema, chest pain concerning for myocardial ischemia, altered mental status, seizures, focal neurologic deficits, peripheral edema, ascites, hematuria, and reduced urine output. Determining gestational age and fetal viability is critical.


Physical Examination Findings
Vital signs require close attention to blood pressure, which may be normal or elevated. Right upper quadrant tenderness may suggest hepatic involvement or subcapsular hematoma. Signs of fluid overload, neurologic abnormalities, and fetal heart tones should be carefully assessed.


Essential Initial Evaluation
Immediate laboratory evaluation includes a complete blood count with platelet count and smear, liver function tests, blood urea nitrogen, creatinine, coagulation profile, magnesium level, and urinalysis for protein. Patient weight should be recorded to assess recent fluid shifts.


Diagnostic Tests And Interpretation
Laboratory findings typically reveal anemia, thrombocytopenia, and evidence of microangiopathic hemolytic anemia on peripheral smear. Elevated lactate dehydrogenase, bilirubin, and reticulocyte count indicate hemolysis. Liver enzymes are elevated, commonly with AST and ALT above 40 IU/L, LDH above 600 IU/L, and bilirubin above 1.2 mg/dL.
Imaging may include chest radiography for suspected pulmonary edema, head CT for altered mental status or focal deficits, and pelvic ultrasound to assess fetal and placental status.


Differential Diagnosis
Gastrointestinal conditions include cholecystitis, pancreatitis, hepatitis, acute fatty liver of pregnancy, and severe reflux disease. Hematologic considerations include gestational thrombocytopenia, idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Neurologic causes include epilepsy, meningitis, encephalopathy, brain tumor, or intracranial hemorrhage. Other considerations include sepsis, pyelonephritis, and substance use.


Prehospital And Early Management Considerations
Patients should be transported in the left lateral decubitus position to avoid inferior vena cava compression. IV access should be established, and seizures managed preferentially with magnesium sulfate. Transport to a facility capable of high-risk obstetric care is essential.


Initial Stabilization And Monitoring
Management begins with airway, breathing, and circulation support. High-flow oxygen is administered, and maternal cardiac and oxygen monitoring initiated. Continuous fetal monitoring and uterine activity assessment are required.


Emergency Department Management
Hypertension is controlled with appropriate antihypertensives while avoiding ACE inhibitors. Magnesium sulfate is administered for seizure prophylaxis or treatment, not for blood pressure control. Obstetric consultation is mandatory, with consideration of neonatology involvement and emergent delivery when indicated.
IV fluids are restricted to prevent worsening capillary leak, typically limited to 60 mL/hr unless dehydration is present. Platelet transfusion is indicated for counts below 20,000/μL or higher thresholds if delivery or surgery is planned. Blood products are administered as needed for anemia or coagulopathy.


Medications
First-line antihypertensives include IV hydralazine or labetalol, titrated to maintain diastolic blood pressure below 110 mm Hg. Magnesium sulfate is given as a loading dose followed by continuous infusion, with monitoring for toxicity. Nitroprusside is reserved for refractory hypertension. Calcium gluconate is available as an antidote for magnesium toxicity.


Disposition And Follow-Up
All patients with HELLP syndrome require admission to an obstetric service for continuous maternal and fetal monitoring. ICU admission is indicated for severe complications such as pulmonary edema, respiratory failure, cerebral edema, or hemodynamic instability. Discharge decisions are made exclusively by obstetric specialists.


Clinical Pearls And Common Errors
Pregnant patients with abdominal pain, elevated liver enzymes, and thrombocytopenia require immediate evaluation for HELLP syndrome, even in the absence of hypertension. Normal blood pressure does not exclude the diagnosis. Prompt stabilization and transfer to a high-risk obstetric facility are critical to reducing maternal and fetal morbidity and mortality.


Picture
0 Comments